CNC vs EYPT · P/E 8.4, rev $103.52B vs rev $1.2M
Centene Corp (CNC) versus Eyepoint Pharmaceuticals Inc (EYPT) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Latest reported CNC revenue for 2026-06-30 was $103.52B. Net income was $2.63B. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. EYPT currently screens at market cap $1.10B.
Not investment advice. Open the CNC and EYPT stock pages for the full models.
Not investment advice.